nitrocefin and Tuberculosis--Multidrug-Resistant

nitrocefin has been researched along with Tuberculosis--Multidrug-Resistant* in 1 studies

Other Studies

1 other study(ies) available for nitrocefin and Tuberculosis--Multidrug-Resistant

ArticleYear
Mutation in an Unannotated Protein Confers Carbapenem Resistance in Mycobacterium tuberculosis.
    Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:3

    β-Lactams are the most widely used antibacterials. Among β-lactams, carbapenems are considered the last line of defense against recalcitrant infections. As recent developments have prompted consideration of carbapenems for treatment of drug-resistant tuberculosis, it is only a matter of time before

    Topics: Amino Acid Sequence; Amino Acid Substitution; Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; beta-Lactam Resistance; Cephalosporins; Clavulanic Acid; DNA, Intergenic; Gene Expression; Genetic Loci; Humans; Meropenem; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Open Reading Frames; Protein Binding; Thienamycins; Tuberculosis, Multidrug-Resistant

2017